Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Research Study Investigating How Well NDec Works in People With Sickle Cell Disease

ClinicalTrials.gov ID: NCT05405114

Public ClinicalTrials.gov record NCT05405114. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicentre Trial Evaluating the Efficacy and Safety of Oral Decitabine Tetrahydrouridine (NDec) in Patients With Sickle Cell Disease

Study identification

NCT ID
NCT05405114
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
96 participants

Conditions and interventions

Interventions

  • NDec - oral decitabine-tetrahydrouridine Drug
  • HU - Hydroxyurea Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 6, 2022
Primary completion
Jul 23, 2025
Completion
Jul 23, 2025
Last update posted
Jun 17, 2026

2022 – 2025

United States locations

U.S. sites
53
U.S. states
27
U.S. cities
40
Facility City State ZIP Site status
University Of South Alabama Mobile Alabama 36617
Keck Medical Center of USC - Outpatient Clinic Los Angeles California 90033
UCSF Oakland Benioff ChildHosp Oakland California 94609
Center for Inherited Blood Dis Orange California 92868
Harbor-UCLA Medical Center Torrance California 90502-2004
Clinical and Transl Res Center Aurora Colorado 80045
Carole&Ray Neag Comp S.C. Ctr Farmington Connecticut 06030
Tova Community Health Inc Wilmington Delaware 19805
Howard University Hospital Department Med Washington D.C. District of Columbia 20060
Howard University Washington D.C. District of Columbia 20060
Foundation for Sickle Cell Disease Research Hollywood Florida 33023
University of Florida, College of Medicine Jacksonville Jacksonville Florida 32209
University of Miami Hospital & Clinics Miami Florida 33136
Emory University School Of Med Atlanta Georgia 30333
Aflac Cancer/Blood Dis CCH Atlanta Georgia 30342
Emory University School Of Med Atlanta Georgia 30342
Augusta University Augusta Georgia 30912
Rush University Med. Cntr Chicago Illinois 60612
Univer Of Illinois at Chicago Chicago Illinois 60612
Tulane Sickle Cell Ctr- So LA Metairie Louisiana 70002
Mass General Cancer Center Boston Massachusetts 02114
Wayne State University/University Health Center Detroit Michigan 48201
Children's Hospitals And Clinics Of Minnesota Minneapolis Minnesota 55404
University of Minnesota_Minneapolis_0 Minneapolis Minnesota 55455
Mississippi Center Advanced Medicine Madison Mississippi 39110
Univ of NE Med Center_Omaha Omaha Nebraska 68198
Cure 4 the Kids Foundation Las Vegas Nevada 89135
Hackensack University Medical Center Hackensack New Jersey 07601
Interfaith Medical Center Brooklyn New York 11238
Queens Hospital Center Jamaica New York 11432-1121
Mount Sinai School of Medicine New York New York 10029
Jacobi Medical Center The Bronx New York 10461
Montefiore Medical Center The Bronx New York 10467
University of North Carlolina-Chapel Hill Chapel Hill North Carolina 27599
Atrium Levine Children's/Atrium Health Charlotte North Carolina 28204
Duke Comprehen Sickle Cell Durham North Carolina 27710
East Carolina Univ-Greenville Greenville North Carolina 27834-4300
East Carolina Univ-Greenville Greenville North Carolina 27834
Dayton Children's Hosptial Dayton Ohio 45404
Univ Oklahoma HSC_Okla City Oklahoma City Oklahoma 73104
University of Oklahoma Health Sciences Center_Oklahoma City Oklahoma City Oklahoma 73104
Penn Comprehensive Hemophilia & Thrombosis Program Philadelphia Pennsylvania 19104
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
St Christopher Hosp for Child Philadelphia Pennsylvania 19134
Hemophilia Center of Western PA Pittsburgh Pennsylvania 15213
Medical Univ of SC Charleston Charleston South Carolina 29425
University Of Tennessee Memphis Tennessee 38163
Baylor College of Medicine Texas Childen's Hospital Houston Texas 77030
Baylor College of Medicine_Houston Houston Texas 77030
Dan L. Duncan Comprehensive Cancer Center Houston Texas 77030
Univ Texas HSC-Houston Houston Texas 77030
University Of Virginia Hospital Charlottesville Virginia 22908
Medical College of Wisconsin & Zablocki VAMC Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05405114, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 17, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05405114 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →